Aravive (ARAV) Competitors $0.04 0.00 (0.00%) As of 04/2/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsSustainabilityTrendsBuy This Stock ARAV vs. FLGC, ORGS, IPA, LPTX, AFMD, BGXX, APRE, ATHA, CSCI, and TXMDShould you be buying Aravive stock or one of its competitors? The main competitors of Aravive include Flora Growth (FLGC), Orgenesis (ORGS), ImmunoPrecise Antibodies (IPA), Leap Therapeutics (LPTX), Affimed (AFMD), Bright Green (BGXX), Aprea Therapeutics (APRE), Athira Pharma (ATHA), COSCIENS Biopharma (CSCI), and TherapeuticsMD (TXMD). These companies are all part of the "pharmaceutical products" industry. Aravive vs. Flora Growth Orgenesis ImmunoPrecise Antibodies Leap Therapeutics Affimed Bright Green Aprea Therapeutics Athira Pharma COSCIENS Biopharma TherapeuticsMD Aravive (NASDAQ:ARAV) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings. Do analysts rate ARAV or FLGC? Flora Growth has a consensus price target of $5.00, indicating a potential upside of 882.32%. Given Flora Growth's stronger consensus rating and higher possible upside, analysts plainly believe Flora Growth is more favorable than Aravive.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aravive 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Flora Growth 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has more volatility and risk, ARAV or FLGC? Aravive has a beta of 2.19, suggesting that its stock price is 119% more volatile than the S&P 500. Comparatively, Flora Growth has a beta of 1.99, suggesting that its stock price is 99% more volatile than the S&P 500. Does the media favor ARAV or FLGC? In the previous week, Flora Growth had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Flora Growth and 0 mentions for Aravive. Flora Growth's average media sentiment score of 1.58 beat Aravive's score of 0.00 indicating that Flora Growth is being referred to more favorably in the news media. Company Overall Sentiment Aravive Neutral Flora Growth Very Positive Is ARAV or FLGC more profitable? Aravive has a net margin of 0.00% compared to Flora Growth's net margin of -30.99%. Aravive's return on equity of 0.00% beat Flora Growth's return on equity.Company Net Margins Return on Equity Return on Assets AraviveN/A N/A N/A Flora Growth -30.99%-268.17%-57.51% Do institutionals and insiders believe in ARAV or FLGC? 35.8% of Aravive shares are held by institutional investors. Comparatively, 36.0% of Flora Growth shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Comparatively, 13.0% of Flora Growth shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community prefer ARAV or FLGC? Aravive received 89 more outperform votes than Flora Growth when rated by MarketBeat users. Likewise, 62.28% of users gave Aravive an outperform vote while only 60.00% of users gave Flora Growth an outperform vote. CompanyUnderperformOutperformAraviveOutperform Votes10462.28% Underperform Votes6337.72% Flora GrowthOutperform Votes1560.00% Underperform Votes1040.00% Which has higher valuation and earnings, ARAV or FLGC? Flora Growth has higher revenue and earnings than Aravive. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAravive$6.99M0.42-$76.32MN/AN/AFlora Growth$59.51M0.17-$57.04M-$1.32-0.39 SummaryAravive and Flora Growth tied by winning 8 of the 16 factors compared between the two stocks. Remove Ads Get Aravive News Delivered to You Automatically Sign up to receive the latest news and ratings for ARAV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ARAV vs. The Competition Export to ExcelMetricAravivePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.95M$6.73B$5.54B$7.50BDividend YieldN/A2.79%4.86%4.04%P/E RatioN/A6.9923.2218.08Price / Sales0.42198.60363.5486.83Price / CashN/A65.6738.1634.64Price / BookN/A5.926.513.99Net Income-$76.32M$142.37M$3.21B$247.18M7 Day PerformanceN/A-7.24%-4.88%-4.25%1 Month PerformanceN/A-10.45%-0.06%-6.87%1 Year PerformanceN/A-14.58%6.62%-3.73% Aravive Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ARAVAraviveN/A$0.04flatN/AN/A$2.95M$6.99M0.0020High Trading VolumeFLGCFlora Growth3.3067 of 5 stars$0.61-6.9%$5.00+726.4%-80.9%$11.76M$59.51M-0.46280Positive NewsGap UpORGSOrgenesisN/A$2.45-27.3%N/AN/A$11.76M$662,000.000.00150Gap UpHigh Trading VolumeIPAImmunoPrecise Antibodies1.8582 of 5 stars$0.38-4.0%$4.00+962.4%-76.6%$11.70M$24.07M-0.4880Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageLPTXLeap Therapeutics2.2708 of 5 stars$0.31-3.6%$4.92+1,511.5%-87.6%$11.69MN/A-0.1640Short Interest ↓Gap DownAFMDAffimed4.2736 of 5 stars$0.72-7.4%$13.50+1,766.7%-90.5%$11.64M$877,000.000.00200Analyst ForecastShort Interest ↓News CoverageGap UpBGXXBright GreenN/AN/AN/AN/A$11.47MN/A-1.002Gap DownAPREAprea Therapeutics2.7519 of 5 stars$2.04-2.4%$15.50+659.8%-71.5%$11.20M$580,000.00-0.737Short Interest ↑High Trading VolumeATHAAthira Pharma1.5022 of 5 stars$0.28-6.6%$13.83+4,755.5%-89.6%$11.12MN/A-0.1040Gap DownCSCICOSCIENS BiopharmaN/A$2.84-6.6%N/AN/A$10.72M$7.60M-0.2420Positive NewsTXMDTherapeuticsMD0.4481 of 5 stars$0.93-5.8%N/A-56.4%$10.67M$1.60M0.00420Analyst ForecastNews CoverageGap Down Remove Ads Related Companies and Tools Related Companies FLGC Competitors ORGS Competitors IPA Competitors LPTX Competitors AFMD Competitors BGXX Competitors APRE Competitors ATHA Competitors CSCI Competitors TXMD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ARAV) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aravive, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aravive With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARAV Stock Free ARAV Stock Alerts